Literature DB >> 32265588

The relationship between dermatological findings and serum interleukin 31 and serum uridine diphosphate glucose ceramide glucosyltransferase levels among patients with chronic kidney disease.

B Güvercin1, K Kaynar1, D A Arıca2, B V Kural3, Ş Ulusoy1, M Cansız1, L B Selçuk2, A Akyüz3, C C Kolaylı4.   

Abstract

BACKGROUND: Cutaneous diseases are observed with increasing duration and severity of renal disease in patients with chronic kidney disease (CKD). This study aimed to elucidate dermatological manifestations at different stages of CKD and determine their relationship with interleukin 31 (IL-31), a T-cell cytokine that induces severe pruritus, and uridine diphosphate (UDP)-glucose ceramide glucosyltransferase (UGCG), an enzyme that metabolizes ceramide, which plays an important role in moisturizing epidermis.
METHODS: In this retrospective cohort study 145 patients with a mean age of 46 ± 17 years were categorized into hemodialysis (group 1), peritoneal dialysis (group 2),  kidney transplant (group 3), CKD (group 4), and healthy control (group 5) groups. Serum IL-31 and  UGCG levels were measured using enzyme-linked immunosorbent assay, and clinical dermatologists evaluated dermatological manifestations.
RESULTS: In the overall cohort, pruritus was significantly and inversely correlated with glomerular filtration rate and serum hemoglobin and albumin levels (p <0.005). Additionally, pruritus was significantly more frequent in group 2 than in group 5; and significantly less frequent in group 3 than in groups 1, 2, and 4 (p =0.01). In group 4, the patients with longitudinal nail ridges had significantly higher serum IL-31 levels than those without longitudinal nail ridges in their nails (p =0.02). Furthermore, in group 2, the patients with pruritus had significantly lower UGCG levels than those without pruritus (p =0.045).
CONCLUSION: IL-31 might play a role in the development of longitudinal nail ridges, whereas UGCG might provide protection from pruritus and xerosis in patients with CKD.  HIPPOKRATIA 2019, 23(2): 75-80. Copyright 2019, Hippokratio General Hospital of Thessaloniki.

Entities:  

Keywords:  Chronic kidney disease; interleukin 31; nail and skin disorders; pruritus; uridine diphosphate glucose ceramide glucosyltransferase

Year:  2019        PMID: 32265588      PMCID: PMC7127917     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  24 in total

1.  Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis.

Authors:  Deepshikha Khanna; Archana Singal; Om Prakash Kalra
Journal:  Postgrad Med J       Date:  2010-11       Impact factor: 2.401

Review 2.  Cutaneous manifestations of chronic kidney disease.

Authors:  Mazen S Kurban; Adel Boueiz; Abdul-Ghani Kibbi
Journal:  Clin Dermatol       Date:  2008 May-Jun       Impact factor: 3.541

Review 3.  Diagnosis of common dermopathies in dialysis patients: a review and update.

Authors:  Alina Markova; Jenna Lester; Joanne Wang; Leslie Robinson-Bostom
Journal:  Semin Dial       Date:  2012-07       Impact factor: 3.455

4.  Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error.

Authors:  J T Daugirdas
Journal:  J Am Soc Nephrol       Date:  1993-11       Impact factor: 10.121

Review 5.  Pruritus in Kidney Disease.

Authors:  Sara A Combs; J Pedro Teixeira; Michael J Germain
Journal:  Semin Nephrol       Date:  2015-07       Impact factor: 5.299

6.  Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis.

Authors:  Mei-Ju Ko; Yu-Sen Peng; Hung-Yuan Chen; Shih-Ping Hsu; Mei-Fen Pai; Ju-Yeh Yang; Su-Ying Wen; Shiou-Hwa Jee; Hon-Yen Wu; Hsien-Ching Chiu
Journal:  J Am Acad Dermatol       Date:  2014-09-27       Impact factor: 11.527

7.  Skin diseases in patients with beta-thalassemia major.

Authors:  Asena Cigdem Dogramaci; Nazan Savas; Burcin Ozer; Nizami Duran
Journal:  Int J Dermatol       Date:  2009-10       Impact factor: 2.736

8.  Urea kinetic modeling in continuous peritoneal dialysis patients. Effect of body composition on the methods for estimating urea volume of distribution.

Authors:  A H Tzamaloukas; G H Murata; D Malhotra; P Sena; A Patron
Journal:  ASAIO J       Date:  1993 Jul-Sep       Impact factor: 2.872

9.  Epidemiology and determinants of pruritus in pre-dialysis chronic kidney disease patients.

Authors:  Berna Solak; Seyyid Bilal Acikgoz; Savas Sipahi; Teoman Erdem
Journal:  Int Urol Nephrol       Date:  2016-01-14       Impact factor: 2.370

10.  Eosinophils are a Major Source of Interleukin-31 in Bullous Pemphigoid.

Authors:  Urda Rüdrich; Manuela Gehring; Eleni Papakonstantinou; Anja Illerhaus; Judith Engmann; Alexander Kapp; Karin Hartmann; N Helge Meyer; Bernhard F Gibbs; Ulrike Raap
Journal:  Acta Derm Venereol       Date:  2018-08-29       Impact factor: 4.437

View more
  2 in total

1.  High Serum IL-31 Concentration Is Associated with Itch among Renal Transplant Recipients.

Authors:  Piotr K Krajewski; Kinga Tyczyńska; Klaudia Bardowska; Piotr Olczyk; Danuta Nowicka-Suszko; Dariusz Janczak; Hanna Augustyniak-Bartosik; Magdalena Krajewska; Jacek C Szepietowski
Journal:  J Clin Med       Date:  2022-07-25       Impact factor: 4.964

2.  The Serum Level of IL-31 in Patients with Chronic Kidney Disease-Associated Pruritus: What Can We Expect?

Authors:  Karolina Świerczyńska; Piotr K Krajewski; Danuta Nowicka-Suszko; Rafał Białynicki-Birula; Magdalena Krajewska; Jacek C Szepietowski
Journal:  Toxins (Basel)       Date:  2022-03-07       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.